Diabetes therapy

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/16 (2006.01) A61K 35/12 (2006.01) A61K 35/23 (2006.01) C07K 14/605 (2006.01) C12N 5/10 (2006.01) C12N 15/85 (2006.01) A61K 48/00 (2006.01)

Patent

CA 2243718

The invention provides a gene therapy method for delivering safe and effective, long-term amounts of GLP-1(7-37)-based proteins useful for treating Type I and Type II diabetes. The invention eliminates the need for subcutaneous injections and is able to provide tight glucose control.

L'invention concerne un procédé de thérapie génique destiné à administrer sur une longue durée des quantités sûres et efficaces de protéines à base de GLP-1 (7-37) utilisées dans le traitement des diabètes de type I et de type II. Cette invention évite d'avoir recours à des injections sous-cutanées et permet de mieux contrôler la glycémie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Diabetes therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diabetes therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diabetes therapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1789944

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.